Gary Charles Robb - Net Worth and Insider Trading
Gary Charles Robb Net Worth
The estimated net worth of Gary Charles Robb is at least $2 Million dollars as of 2024-11-29. Gary Charles Robb is the Chief Business Officer of Corcept Therapeutics Inc and owns about 29,528 shares of Corcept Therapeutics Inc (CORT) stock worth over $2 Million. Details can be seen in Gary Charles Robb's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gary Charles Robb has not made any transactions after 2024-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gary Charles Robb
Gary Charles Robb Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary Charles Robb owns 1 companies in total, including Corcept Therapeutics Inc (CORT) .
Click here to see the complete history of Gary Charles Robb’s form 4 insider trades.
Insider Ownership Summary of Gary Charles Robb
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2024-10-01 | CHIEF FINANCIAL OFFICER |
Gary Charles Robb Latest Holdings Summary
Gary Charles Robb currently owns a total of 1 stock. Gary Charles Robb owns 29,528 shares of Corcept Therapeutics Inc (CORT) as of November 22, 2024, with a value of $2 Million.
Latest Holdings of Gary Charles Robb
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2024-11-22 | 29,528 | 58.60 | 1,730,341 |
Holding Weightings of Gary Charles Robb
Gary Charles Robb Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary Charles Robb has made a total of 18 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Corcept Therapeutics Inc is the sale of 2,609 shares on November 22, 2024, which brought Gary Charles Robb around $146,626.
Insider Trading History of Gary Charles Robb
- 1
Gary Charles Robb Trading Performance
GuruFocus tracks the stock performance after each of Gary Charles Robb's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary Charles Robb is 47.23%. GuruFocus also compares Gary Charles Robb's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary Charles Robb within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gary Charles Robb's insider trading performs compared to the benchmark.
Performance of Gary Charles Robb
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.41 | | | | | |
| Relative Return to S&P 500(%) | 21.34 | | | | | |
Gary Charles Robb Ownership Network
Gary Charles Robb Owned Company Details
What does Corcept Therapeutics Inc do?
Who are the key executives at Corcept Therapeutics Inc?
Gary Charles Robb is the CHIEF FINANCIAL OFFICER of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Accounting Officer Joseph Douglas Lyon , Chief Development Officer William Guyer , and See Remarks Sean Maduck .
Corcept Therapeutics Inc (CORT) Insider Trades Summary
Over the past 18 months, Gary Charles Robb made 7 insider transaction in Corcept Therapeutics Inc (CORT) with a net sale of 51,303. Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 71,411 shares made by Joseph Douglas Lyon , a net sale of 30,950 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .
In summary, during the past 3 months, insiders sold 47,220 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 47,220 shares. During the past 18 months, 524,119 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 524,119 shares.
Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corcept Therapeutics Inc Insider Transactions
Gary Charles Robb Mailing Address
Above is the net worth, insider trading, and ownership report for Gary Charles Robb. You might contact Gary Charles Robb via mailing address: C/o 149 Commonwealth Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
